Niagen Bioscience (NAGE) Change in Inventory (2011 - 2026)

Niagen Bioscience (NAGE) has reported Change in Inventory for 14 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Inventory rose 79.28% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $13.2 million (up 1108.78% YoY), while the FY2025 annual figure was $11.6 million, up 318.17% from the prior year.
• Change in Inventory grew to $3.6 million in Q1 2026 per NAGE's latest filing, from $2.0 million in the prior quarter.
• Across five years, Change in Inventory topped out at $4.4 million in Q3 2025 and bottomed at -$2.8 million in Q1 2023.
• Historically, Change in Inventory has averaged $635235.3 across 5 years, with a median of $446000.0 in 2022.
• Annual changes were most pronounced in 2023 — Change in Inventory surged 656.41% — and 2024, when it plunged 1613.85%.
• Niagen Bioscience's Change in Inventory stood at -$959000.0 in 2022, then surged by 298.23% to $1.9 million in 2023, then sank by 171.12% to -$1.4 million in 2024, then jumped by 250.59% to $2.0 million in 2025, then surged by 75.49% to $3.6 million in 2026.
• Business Quant data shows NAGE's Change in Inventory at $3.6 million in Q1 2026, $2.0 million in Q4 2025, and $4.4 million in Q3 2025.